Literature DB >> 22142805

Inpatient care for septicemia or sepsis: a challenge for patients and hospitals.

Margaret Jean Hall1, Sonja N Williams, Carol J DeFrances, Aleksandr Golosinskiy.   

Abstract

Septicemia and sepsis are serious bloodstream infections that can rapidly become life-threatening. They arise from various infections, including those of the skin, lungs, abdomen, and urinary tract. Patients with these conditions are often treated in a hospital’s intensive care unit. Early aggressive treatment increases the chance of survival. In 2008, an estimated $14.6 billion was spent on hospitalizations for septicemia, and from 1997 through 2008, the inflation-adjusted aggregate costs for treating patients hospitalized for this condition increased on average annually by 11.9%. Despite high treatment expenditures, septicemia and sepsis are often fatal. Those who survive severe sepsis are more likely to have permanent organ damage, cognitive impairment, and physical disability. Septicemia is a leading cause of death. The purpose of this report is to describe the most recent trends in care for hospital inpatients with these diagnoses. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Year:  2011        PMID: 22142805

Source DB:  PubMed          Journal:  NCHS Data Brief        ISSN: 1941-4935


  150 in total

Review 1.  Balance Between the Proinflammatory and Anti-Inflammatory Immune Responses with Blood Transfusion in Sepsis.

Authors:  Teresa C Rice; Amanda M Pugh; Charles C Caldwell; Barbara St Pierre Schneider
Journal:  Crit Care Nurs Clin North Am       Date:  2017-06-23       Impact factor: 1.326

2.  B-1a Cells Protect Mice from Sepsis: Critical Role of CREB.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

3.  Inducible Nitric Oxide Synthase in Circulating Microvesicles: Discovery, Evolution, and Evidence as a Novel Biomarker and the Probable Causative Agent for Sepsis.

Authors:  Robert J Webber; Richard M Sweet; Douglas S Webber
Journal:  J Appl Lab Med       Date:  2019-01

4.  Increased fluid administration in the first three hours of sepsis resuscitation is associated with reduced mortality: a retrospective cohort study.

Authors:  Sarah J Lee; Kannan Ramar; John G Park; Ognjen Gajic; Guangxi Li; Rahul Kashyap
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

5.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

6.  Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED.

Authors:  Geoffrey E Hayden; Rachel E Tuuri; Rachel Scott; Joseph D Losek; Aaron M Blackshaw; Andrew J Schoenling; Paul J Nietert; Greg A Hall
Journal:  Am J Emerg Med       Date:  2015-08-28       Impact factor: 2.469

7.  [Sepsis : putting knowledge into practice].

Authors:  S N Stehr; I Woest; C S Hartog; K Reinhart
Journal:  Internist (Berl)       Date:  2013-01       Impact factor: 0.743

8.  Human microparticles generated during sepsis in patients with critical illness are neutrophil-derived and modulate the immune response.

Authors:  Priya S Prakash; Charles C Caldwell; Alex B Lentsch; Timothy A Pritts; Bryce R H Robinson
Journal:  J Trauma Acute Care Surg       Date:  2012-08       Impact factor: 3.313

9.  HMG-CoA Reductase Inhibitors for Prevention and Treatment of Severe Sepsis.

Authors:  Joel D Mermis; Steven Q Simpson
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

Review 10.  Carbon monoxide in the treatment of sepsis.

Authors:  Kiichi Nakahira; Augustine M K Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-23       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.